Jim Cramer Says Don't Trade Stocks Based on Trump Cabinet Nominations

Investors shouldn't be buying certain healthcare stocks based on Donald Trump's nomination of Tom Price as HHS chief, says Jim Cramer.
Publish date:

TheStreet's Jim Cramer says investors shouldn't be making stock trades based on who President-elect Donald Trump is nominating to his Cabinet. Trump has selected Rep. Tom Price, R-Ga., and an Obamacare critic to head the Department of Health and Human Services. Cramer says investors shouldn't be buying stocks such as Stryker (SYK) - Get Report  and Zimmer Biomet (ZBH) - Get Report  based on the nomination, noting that companies reported weak quarters. "This is a little bit nuts when you see a bunch of stocks go up on an appointment," says Cramer. He said investors should ring the register because he doesn't want people to get hurt.